Penobscot Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $360K | Hold |
2,848
| – | – | 0.02% | 258 |
|
|
2026
Q1 | $397K | Sell |
2,848
-352
| -11% | -$49.3K | 0.03% | 242 |
|
|
2025
Q4 | $393K | Hold |
3,200
| – | – | 0.03% | 242 |
|
|
2025
Q3 | $355K | Hold |
3,200
| – | – | 0.03% | 256 |
|
|
2025
Q2 | $355K | Hold |
3,200
| – | – | 0.03% | 246 |
|
|
2025
Q1 | $359K | Hold |
3,200
| – | – | 0.03% | 241 |
|
|
2024
Q4 | $296K | Buy |
3,200
+500
| +19% | +$45K | 0.03% | 256 |
|
|
2024
Q3 | $226K | Buy |
+2,700
| New | +$206K | 0.02% | 301 |
|
|
2024
Q1 | – | Sell |
-2,700
| Closed | -$219K | – | 302 |
|
|
2023
Q4 | $219K | Hold |
2,700
| – | – | 0.03% | 277 |
|
|
2023
Q3 | $202K | Hold |
2,700
| – | – | 0.03% | 267 |
|
|
2023
Q2 | $208K | Hold |
2,700
| – | – | 0.03% | 224 |
|
|
2023
Q1 | $224K | Hold |
2,700
| – | – | 0.04% | 211 |
|
|
2022
Q4 | $232K | Buy |
+2,700
| New | +$214K | 0.04% | 207 |
|
|
2022
Q1 | – | Sell |
-2,820
| Closed | -$205K | – | 242 |
|
|
2021
Q4 | $205K | Buy |
+2,820
| New | +$194K | 0.03% | 238 |
|
|
2020
Q4 | – | Sell |
-3,360
| Closed | -$212K | – | 212 |
|
|
2020
Q3 | $212K | Hold |
3,360
| – | – | 0.04% | 196 |
|
|
2020
Q2 | $259K | Hold |
3,360
| – | – | 0.05% | 174 |
|
|
2020
Q1 | $251K | Sell |
3,360
-150
| -4% | -$10.4K | 0.06% | 162 |
|
|
2019
Q4 | $228K | Sell |
3,510
-120
| -3% | -$7.82K | 0.04% | 185 |
|
|
2019
Q3 | $230K | Sell |
3,630
-1,000
| -22% | -$65.4K | 0.05% | 185 |
|
|
2019
Q2 | $313K | Hold |
4,630
| – | – | 0.06% | 162 |
|
|
2019
Q1 | $301K | Sell |
4,630
-110
| -2% | -$7.31K | 0.06% | 164 |
|
|
2018
Q4 | $296K | Sell |
4,740
-2,240
| -32% | -$157K | 0.07% | 157 |
|
|
2018
Q3 | $539K | Sell |
6,980
-70
| -1% | -$5.29K | 0.12% | 144 |
|
|
2018
Q2 | $499K | Hold |
7,050
| – | – | 0.12% | 145 |
|
|
2018
Q1 | $532K | Hold |
7,050
| – | – | 0.13% | 142 |
|
|
2017
Q4 | $505K | Sell |
7,050
-200
| -3% | -$15.2K | 0.14% | 125 |
|
|
2017
Q3 | $587K | Buy |
7,250
+40
| +0.6% | +$3.06K | 0.18% | 114 |
|
|
2017
Q2 | $510K | Buy |
7,210
+700
| +11% | +$46.6K | 0.16% | 120 |
|
|
2017
Q1 | $442K | Sell |
6,510
-861
| -12% | -$60.5K | 0.15% | 121 |
|
|
2016
Q4 | $528K | Buy |
7,371
+680
| +10% | +$50.5K | 0.18% | 110 |
|
|
2016
Q3 | $529K | Buy |
6,691
+200
| +3% | +$16.2K | 0.19% | 106 |
|
|
2016
Q2 | $541K | Buy |
6,491
+470
| +8% | +$41.7K | 0.19% | 107 |
|
|
2016
Q1 | $553K | Buy |
6,021
+2,740
| +84% | +$247K | 0.21% | 110 |
|
|
2015
Q4 | $332K | Hold |
3,281
| – | – | 0.1% | 150 |
|
|
2015
Q3 | $322K | Hold |
3,281
| – | – | 0.11% | 153 |
|
|
2015
Q2 | $384K | Buy |
3,281
+381
| +13% | +$41.6K | 0.12% | 149 |
|
|
2015
Q1 | $285K | Sell |
2,900
-200
| -6% | -$20.3K | 0.09% | 164 |
|
|
2014
Q4 | $292K | Sell |
3,100
-400
| -11% | -$41.4K | 0.09% | 154 |
|
|
2014
Q3 | $373K | Buy |
+3,500
| New | +$343K | 0.12% | 130 |
|
Other funds holding GILD
Penobscot Investment Management's GILD Position: Q2 2026 in Review
Penobscot Investment Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,848 shares worth $360K. The position accounts for 0.02% of the portfolio, ranked #258.
Penobscot Investment Management first reported a position in GILD in Q3 2014 and has held it in 39 quarters since. The position peaked at $587K in Q3 2017. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Penobscot Investment Management held 2,848 shares of Gilead Sciences worth $360K as of Q2 2026.
- Penobscot Investment Management left its Gilead Sciences share count unchanged in Q2 2026.
- Gilead Sciences made up 0.02% of Penobscot Investment Management's portfolio in Q2 2026, its #258 holding.
- Penobscot Investment Management first reported a position in Gilead Sciences in Q3 2014 and has held it in 39 quarters since.
- Penobscot Investment Management's Gilead Sciences position peaked at $587K in Q3 2017.
- 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.